We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-2.27%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.23B
AUM Growth
-$236M
Cap. Flow
-$124M
Cap. Flow %
-3.82%
Top 10 Hldgs %
42.87%
Holding
405
New
25
Increased
177
Reduced
155
Closed
37

Top Buys

Rank Stock Value
1
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$110M
2
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$32.5M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$18.7M
4
NVDA icon
NVIDIA
NVDA
+$16.1M
5
MU icon
Micron Technology
MU
+$16M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$87.4M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$62M
3
HYMB icon
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
+$61.4M
4
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$30.1M
5
DOCU
DocuSign
DOCU
+$21.3M

Sector Composition

Rank Sector Weight
1 Technology 14.38%
2 Healthcare 6.83%
3 Financials 4.82%
4 Industrials 3.49%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VLTO icon
351
Veralto
VLTO
$23.1B
$211K 0.01%
2,164
-11
-0.5% -$1.1K
ADSK icon
352
Autodesk
ADSK
$49.6B
$209K 0.01%
800
+18
+2% +$5.12K
INVA icon
353
Innoviva
INVA
$1.53B
$205K 0.01%
11,324
-573
-5% -$10.3K
IWS icon
354
iShares Russell Mid-Cap Value ETF
IWS
$16B
$202K 0.01%
1,607
+5
+0.3% +$651
ELV icon
355
Elevance Health
ELV
$83B
$201K 0.01%
+462
New +$185K
VEU icon
356
Vanguard FTSE All-World ex-US ETF
VEU
$68B
$200K 0.01%
+3,298
New +$199K
FOLD
357
DELISTED
Amicus Therapeutics
FOLD
$189K 0.01%
23,210
-1,060
-4% -$9.81K
CRF
358
Cornerstone Total Return Fund
CRF
$1.15B
$188K 0.01%
26,766
+699
+3% +$5.67K
DMRC icon
359
Digimarc Corp
DMRC
$161M
$170K 0.01%
+13,271
New +$380K
EQX icon
360
Equinox Gold
EQX
$7.56B
$147K ﹤0.01%
+21,400
New +$137K
IOVA icon
361
Iovance Biotherapeutics
IOVA
$1.93B
$107K ﹤0.01%
32,167
-1,458
-4% -$7.52K
AUR icon
362
Aurora
AUR
$14.2B
$74K ﹤0.01%
11,000
+1,000
+10% +$7.16K
IRWD icon
363
Ironwood Pharmaceuticals
IRWD
$709M
$60.3K ﹤0.01%
40,994
-1,681
-4% -$4K
UROY
364
Uranium Royalty Corp
UROY
$1.3B
$52.8K ﹤0.01%
+30,000
New +$64.3K
RBBN icon
365
Ribbon Communications
RBBN
$379M
$39.3K ﹤0.01%
10,030
– –
IBRX icon
366
ImmunityBio
IBRX
$7.28B
$30.1K ﹤0.01%
10,000
– –
LCID icon
367
Lucid Motors
LCID
$3.04B
$26.6K ﹤0.01%
+1,100
New +$29.4K
MRSN
368
DELISTED
Mersana Therapeutics
MRSN
$4.84K ﹤0.01%
563
-37
-6% -$571
A icon
369
Agilent Technologies
A
$39.5B
– –
-93,386
Closed -$12.5M
ARCC icon
370
Ares Capital
ARCC
$13.8B
– –
-17,625
Closed -$386K
AWP
371
abrdn Global Premier Properties Fund
AWP
$369M
– –
-3,383
Closed -$39.2K
BAM icon
372
Brookfield Asset Management
BAM
$82.9B
– –
-3,742
Closed -$203K
BKNG icon
373
Booking.com
BKNG
$151B
– –
-1,050
Closed -$208K
BN icon
374
Brookfield
BN
$107B
– –
-11,554
Closed -$443K
CACI icon
375
CACI
CACI
$11.3B
– –
-500
Closed -$202K
13 14
15
16 17

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

Grimes & Company's Q1 2025 Portfolio in Review

As of Q1 2025, Grimes & Company held 405 positions worth $3.23B, down 6.8% from $3.47B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Grimes & Company withdrew a net $124M in Q1 2025, closing 37 positions and reducing 155 holdings. Its most notable exit was State Street Materials Select Sector SPDR ETF, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grimes & Company opened a new position in State Street Financial Select Sector SPDR ETF worth $18.6M.

  • Grimes & Company's largest Q1 2025 buy was State Street Financial Select Sector SPDR ETF: 372,475 shares worth $18.6M.
  • Grimes & Company added most to iShares Core MSCI EAFE ETF in Q1 2025, an estimated $110M increase.
  • Grimes & Company's biggest Q1 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $87.4M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q1 2025, selling an estimated $13.9M.
  • Grimes & Company's ten largest holdings make up 43% of its $3.23B portfolio in Q1 2025.
  • Grimes & Company opened 25 new positions and closed 37 in Q1 2025.
  • Grimes & Company's portfolio value fell 6.8% quarter-over-quarter to $3.23B.

Based on Grimes & Company's 13F filing for Q1 2025, filed 17 Apr 2025.